Aptila Biotech
PrivateLast Round
Seed
Mar 25, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Aptila Biotech GmbH is a biotechnology company that develops AI-powered software for processing mass spectrometry proteomics data.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Healthcare Analytics, Drug Discovery
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aptila Biotech Comparables
Compare Aptila Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MSAID GmbH | 84% | |
| Bioinformatics Solutions Inc. | 77% | |
| Matrix Science | 76% | |
Aptila Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 25, 2025 |
Aptila Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ascenion | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 608% MoM.
- Apr 5, 2026
Monthly visitors grew 142% MoM, reaching 1.5K.
Aptila Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aptila Biotech's valuation, stock price, and market status.